
Oncotarget
Can the Creatine Shuttle be Targeted to Fight Colorectal Cancer?
May 26, 2023
The podcast delves into the intriguing role of the creatine shuttle in cancer metabolism, specifically its potential in tackling colorectal cancer. Researchers explore how inhibiting creatine kinase B and mitochondrial creatine kinase can suppress growth, stemness, and metastasis in colorectal cancer cells, offering a promising therapeutic strategy.
06:44
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Creatine shuttle is a source of energy for aggressive cancer cells, implicating it in cancer progression.
- Inhibiting creatine kinase enzymes through DNFB showed promising results in reducing CRC growth and metastasis.
Deep dives
Creatine Shuttle in Colorectal Cancer
In the study, researchers analyzed the role of the creatine shuttle in colorectal cancer cells and its potential as a therapeutic target. The creatine shuttle system, involving creatine kinase enzymes, plays a key role in cellular energy metabolism, notably in high-energy demanding tissues like muscle and brain. The team investigated inhibiting creatine kinase B and mitochondrial creatine kinase with DNFB, which resulted in reduced cell growth, stemness, mitochondrial function, and cancer metastasis. Blocking these enzymes through DNFB showed promising results in inhibiting CRC progression and metastasis, suggesting a potential therapeutic strategy.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.